True. No point saying you’re the best in class if you don’t get the evidence to prove it!
A slight concern I have is this: team looks really good, very well qualified scientists for sure, chemists etc ….but is it one of those companies that weighted too much to academia and less experienced getting clinical patient projects moving quickly. .
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-28
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
-0.005(6.85%) |
Mkt cap ! $18.46M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.3¢ | 6.8¢ | $10.78K | 154.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16129 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 21334 | 1 |
View Market Depth
| Last trade - 15.59pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
-0.005 ( 5.56 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.1¢ | 6.8¢ | 10032 | ||
| Last updated 15.59pm 13/06/2024 ? | |||||
| ATX (ASX) Chart |